| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 57,596 | 53,326 | 45,806 | 47,681 | | Cost of Revenue | 18,597 | 17,889 | 15,929 | 15,326 | | | Gross Profit | 38,999 | 35,437 | 29,877 | 32,355 | | | Operating Expenses | | Research Development | 11,796 | 9,886 | 9,734 | 10,250 | | Selling General and Administrative | 31,872 | 29,766 | 26,105 | 27,622 | | Non Recurring |
-
|
-
|
-
| 1,447 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,419) | (4,215) | (5,962) | (6,964) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,635) | (2) | 414 | 388 | | Earnings Before Interest And Taxes | (24,304) | (4,217) | (5,548) | (6,576) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (24,304) | (4,217) | (5,548) | (6,576) | | Income Tax Expense | 372 | 281 | 213 | 201 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (24,676) | (4,498) | (5,761) | (6,777) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (24,676) | (4,498) | (5,761) | (6,777) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,676) | ($4,498) | ($5,761) | ($6,777) |
|
1.52% Nasdaq 0.00%
Income Statement
